CKAP4-GEZIELTES ANTITUMORMITTEL
European patent · EP3287143 · In force
Register entry
- Publication number
- EP3287143
- Application number
- EP16755122
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 28, 2016
- Published
- Feb 28, 2018
- Granted
- Mar 4, 2026
- Protection ends at the latest
- Jan 27, 2036
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 39/395 (2006.01)A61K 31/7105 (2006.01)A61K 31/713 (2006.01)A61K 45/00 (2006.01)A61K 48/00 (2006.01)A61K 49/00 (2006.01)A61P 35/00 (2006.01)A61P 35/02 (2006.01)G01N 33/15 (2006.01)G01N 33/50 (2006.01)
- Priority
- JP 2015038343 27.02.2015
- PCT application
- PCT/JP2016/052485 28.01.2016
- PCT publication
- WO2016/136372 01.09.2016
- Filing language
- Japanese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 4, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 04.03.2026
Parties
Inventor
KIKUCHI, Akira
Suita-shi Osaka 565-0871, JP
FUMOTO, Katsumi
Suita-shi Osaka 565-0871, JP
KIMURA, Hirokazu
Suita-shi Osaka 565-0871, JP
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.